基于肠道菌群探讨中医从脾胃论治代谢相关脂肪性肝病的理论基础

To Explore the Theoretical Basis of Spleen and Stomach Treatment of Metabolic Associated Fatty Liver Disease Based on Intestinal Flora

扫码查看

原文链接

NETL
NSTL
万方数据

中文摘要：肠道菌群失调与代谢相关脂肪性肝病(metabolic associated fatty liver disease,MAFLD)的关系密切,调节肠道菌群可以改善MAFLD.从脾胃论治乃中医临床肝病经典治疗方法,临床疗效显著,调节肠道菌群成为从脾胃论治MAFLD新的研究途径.笔者从肠道菌群入手阐述中医从脾胃论治MAFLD的机制,为中医从脾胃论治MAFLD提供现代生物学基础.

外文摘要：Metabolic associated fatty liver disease(MAFLD)is closely related to intestinal flora disorders,and regulation of intestinal flora can improve MAFLD.Treating MAFLD by spleen and stomach is a classic method of traditional Chinese medicine with remarkable clinical effect.Regulating intestinal flora has become a new research approach for treating MAFLD by spleen and stomach.The authors elaborate the mechanism of spleen and stomach treatment of MAFLD from intestinal flora in order to provide a modern biological basis for spleen and stomach treatment of MAFLD.

外文关键词：

metabolic associated fatty liver diseasethe spleen and stomachintestinal flora

作者：

张荣、徐强、窦婧、王晓波、王宏峰、王晓忠

展开 >

作者单位：

新疆维吾尔自治区中医医院,新疆乌鲁木齐 830000

关键词：

代谢相关脂肪性肝病脾胃肠道菌群

出版年：

2024

DOI：